Logo 1 Logo 2

Clinical Trial Details

Trial ID: L1636
Source ID: NCT03194633
Associated Drug: Nifedipine Controlled-Release Tablets(Nifedipine Gits, Adalat, Baya1040)
Title: Effectiveness and Tolerability of Long-Acting Nifedipine Gastrointestinal Therapeutic System in Chronic Kidney Disease With Uncontrolled Hypertension Patients, a Prospective, Multicenter, Observational Study
Acronym: ADRENAL
Status: COMPLETED
Study Results: NO
Results:
Conditions: Hypertension
Interventions: DRUG: Nifedipine controlled-release tablets(Nifedipine GITS, ADALAT, BAYA1040)
Outcome Measures: Primary: Change in office systolic blood pressure from baseline to week 12, Change in office systolic blood pressure from baseline to week 12, At week 12 | Secondary: Change in office diastolic blood pressure from baseline to week 12, Change in office diastolic blood pressure from baseline to week 12, At week 12|Change in systolic blood pressure and diastolic blood pressure from baseline to week 12 according to baseline SBP stratification, Change in systolic blood pressure and diastolic blood pressure from baseline to week 12 according to baseline SBP stratification, stratified by two subgroups baseline, SBP 140-160 mmHg and ≥ 160 mmHg, At week 12|Change in systolic blood pressure and diastolic blood pressure from baseline to week 12 at different stages of Chronic Kidney Disease, Change in systolic blood pressure and diastolic blood pressure from baseline to week 12 at different stages of Chronic Kidney Disease, stage 1 to stage 5, At week 12|Systolic blood pressure and diastolic blood pressure control rate at week 12, Systolic blood pressure and diastolic blood pressure control rate at week 12, At week 12|Number of participants with adverse events and serious adverse events, At week 12
Sponsor/Collaborators: Sponsor: Bayer
Gender: ALL
Age: ADULT, OLDER_ADULT
Phases:
Enrollment: 871
Study Type: OBSERVATIONAL
Study Designs: Observational Model: |Time Perspective: p
Start Date: 2017-07-10
Completion Date: 2020-08-28
Results First Posted:
Last Update Posted: 2021-07-09
Locations: Many Locations, Multiple Locations, China
URL: https://clinicaltrials.gov/show/NCT03194633